CoagulationDisorders near Staten Island, NY

Biography: Dr. Laura S. Munoz Arcos is an Assistant Professor of Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine and an Assistant Attending Physician at NewYork-Presbyterian Hospital.Dr. Munoz Arcos earned her medical degree from Universidad del Valle in Colombia, her home country. She then completed an internal medicine residency at Montefiore Medical Center/Albert Einstein College of Medicine in the Bronx, NY, followed by a Hematology and Oncology fellowship at Weill Cornell Medicine/NewYork-Presbyterian Hospital, where she served as Chief Fellow in her final year. During her fellowship, Dr. Munoz Arcos gained extensive clinical experience in treating all types of breast cancer while conducting translational research on liquid biopsy in breast cancer at Dr. Massimo Cristofanilli's laboratory. Her research focuses on identifying predictors of response to therapy in hormone receptor-sensitive metastatic breast cancer. In recognition of her work, she received the 2023 Conquer Cancer American Society of Clinical Oncology (ASCO) Young Investigator Award, a prestigious honor granted to only 100 recipients annually. Following the completion of her fellowship, Dr. Munoz Arcos joined the Division of Hematology and Medical Oncology as a faculty member, where she is focused on the treatment of breast cancer.

Biography: Dr. Chris Hackett received his BS in Biological Sciences from Stanford University in 2000. After doing biomedical research in industry and academia, he then pursued graduate studies in cancer genomics at the University of California, San Francisco, where he earned his PhD in 2010. Seeking to become a physician-scientist, he then earned his medical degree (MD) from the University of Minnesota in 2014. He then completed his Internal Medicine Residency at NewYork-Presbyterian/Weill Cornell Medical Center, followed by a fellowship in Medical Oncology at Memorial Sloan Kettering Cancer Center (MSK), where he focused on solid tumor oncology in the clinic and carried out laboratory research to design T cell therapies for cancer. Following fellowship, Dr. Hackett was an attending on the Cellular Therapeutics Service at MSK, where he focused on treating patients with CAR T cells, Tumor Infiltrating Lymphocytes (TIL) and other cell therapies. In 2023, he joined the Bone Marrow Transplant Service at Weill Cornell Medicine and NewYork-Presbyterian Hospital, where he continues to both treat patients with cellular therapies and conduct research to develop new cell therapies for solid tumors.

Biography: Stephanie Purisch, MD is a maternal-fetal medicine specialist and assistant professor of obstetrics and gynecology at Columbia University Irving Medical Center. She joined the Division of Maternal-Fetal Medicine at Columbia after completing residency in obstetrics and gynecology at the Hospital of the University of Pennsylvania and fellowship in maternal-fetal medicine at Columbia University. Dr. Purisch is the co-director of the Mothers Center Heart Program, which provides comprehensive, multidisciplinary clinical care to women with cardiovascular disease who are pregnant or contemplating pregnancy. Dr. Purisch's primary clinical and research interest is the care of women with medically complicated pregnancies. In addition to cardiac disease in pregnancy, she also has expertise caring for pregnant women with underlying maternal pulmonary, endocrine, rheumatologic, and hematologic diseases.

Biography: Maria Andrikopoulou MD, PhD is a maternal-fetal medicine specialist and Assistant Professor of Obstetrics and Gynecology at Columbia University Irving Medical Center. She joined the Division of Maternal-Fetal Medicine at Columbia after completing her residency in Obstetrics and Gynecology at NYU Winthrop University Hospital, and fellowship in Maternal-Fetal Medicine at Columbia University. Dr. Andrikopoulou specializes in the care of high-risk pregnancies, including women with medical complications and fetal anomalies. Her primary clinical and research interests include prenatal diagnosis, sonographic evaluation of fetal malformations and fetal echocardiogram. Dr. Andrikopoulou has presented at many national conferences and published several peer-reviewed research manuscripts and book chapters, focusing on clinical obstetrics, fetal ultrasound and perinatal epidemiology. She is a member of the American College of Obstetricians and Gynecologists, Society for Maternal-Fetal Medicine and International Society of Ultrasound in Obstetrics and Gynecology.

Biography: Dr. Vaibhav Patel, MD is a Hematology Specialist who practices in New York, NY. He is 38 years old. Dr. Vaibhav Patel, MD is affiliated with Mount Sinai Queens, Mount Sinai Brooklyn and Mount Sinai Hospital.

Biography: Pawel Muranski, MD, trained as a Hematologist and Oncologist at the Hematology Branch of the National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH) in Bethesda, Maryland where he subsequently worked as a faculty in the Stem Cell Allogeneic Transplantation Section. He joined Columbia University in 2017 as the Director of Cellular Immunotherapy. Dr. Muranski specializes in bone marrow transplant (BMT).

Biography: Dr. Bobak Parang completed his undergraduate studies at the University of Pennsylvania, where he majored in Biology. He subsequently earned his MD and PhD from Vanderbilt University School of Medicine. He then joined the Weill Cornell Medicine Physician Scientist Training Program where he completed his internal medicine residency and hematology / medical oncology fellowship. During his last year of fellowship, Dr. Parang served as Chief Fellow. As a member of the Weill Cornell Medicine faculty, Dr. Parang is a physician-scientist whose clinical and research interests are focused on lung cancer drug resistance and metastases.

Biography: Caitlin Gribbin, MD, is an Instructor in Medicine within the Division of Hematology and Oncology at Weill Cornell Medical Center. After earning her B.A. from Cornell University, Dr. Gribbin received her Medical Degree as well as Masters in Science from Weill Cornell Medical College. She completed her Internship and Residency as well as subsequent Fellowship training in Hematology and Oncology within the Medical Research Track at Weill Cornell Medicine/NewYork-Presbyterian Hospital. As a faculty member at Weill Cornell, Dr. Gribbin specializes in treating patients with lymphoma using cellular therapies, including chimeric antigen receptor (CAR) T cell therapy. She is simultaneously focused on leading clinical and translational research studies aimed at improving lymphoma treatments by bringing novel scientific discoveries to patients. Dr. Gribbin has co-authored numerous publications and presentations at national and international meetings and has received several research grants, including the American Society of Clinical Oncology (ASCO) Young Investigator Award, the Lymphoma Research Foundation (LRF) Scientific Research Mentoring Program Award, and the Burroughs Wellcome Fund Award.

Biography: Manuela Orjuela-Grimm is a molecular epidemiologist and pediatric oncologist whose research focuses on vulnerability (including social) to environmental exposures, gene-nutrient/ environment interactions during windows of susceptibility such as pregnancy, early childhood, adolescence and the development of later genetic and epigenetic changes contributing to poorer health outcomes in childhood and adolescence. She leads EpiRbMx, a long-standing case control/ case series study examining exposure to methyl donors, folate pathway metabolism and risk for retinoblastoma in collaboration with a multidisciplinary team of investigators including the Hospital Infantil de Mexico, the Hospital de Pediatria at the Instituto Mexicano de Seguro Social (IMSS), the Instituto Nacional de Salud Publica (INSP), and the University of Toronto. In collaboration with INSP researchers, Dr. Orjuela is involved in multiple studies examining the intersection between food security, folate-related dietary intake, dietary diversity and environmental exposures in central Mexico, and in immigrants in New York. Interests: social contributors to dietary exposures, gene-nutrient interactions; one carbon donor metabolism; methylation; nutrient and environmental exposures during early life and later genetic and epigenetic effects; dietary assessment in Mexico, in populations on the move in Latin America; effects of acculturation and early life migration on nutrient/ environmental exposures in US Latinos.

Biography: Originally from Columbus, OH, SunilIyercompleted his undergraduate studies at Washington University in St. Louis. He then completed his medical education and training at the University of Miami, where he served as chief hematology/oncology fellow. He has a strong interest in leukemia, particularly in the genomics and treatment of acute lymphoblastic leukemia.